Treatment of Chronic Leukemia, Sarcoma, Hodgkin’s Disease, and Cancer with Rubidomycin
Chronic myelocytic period. Many therapeutic agents, among which Busulfan and radiotherapy occupy the first rank but which also include 6-mercaptopurine, dibromomannitol, and hydroxyurea, can bring about good remissions in chronic myeloid leukemia. There are thus two important questions to answer in relation to the use of rubidomycin as a therapeutic agent: 1. can it bring about remission in this condition? and 2. what advantages does it have over the drugs already known? It is easy at present to answer the first of these questions, for rubidomycin is indeed very effective. It is difficult to answer the second.
KeywordsComplete Remission Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia Acute Leukemia White Cell Count
Unable to display preview. Download preview PDF.